Bone remodeling: A review of the bone microenvironment perspective for fragility fracture (osteoporosis) of the hip

被引:31
|
作者
Fazzalari, Nicola L. [1 ,2 ]
机构
[1] Inst Med & Vet Sci, Div Tissue Pathol, Bone & Joint Res Lab, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Discipline Pathol, Adelaide, SA, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
Bone remodeling; Formation surface; Resorption surface; Fragility fracture; Osteoporosis;
D O I
10.1016/j.semcdb.2008.08.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Bone remodeling is an active process throughout the skeleton. The concept of bone turnover surface has been developed and reported in the peer reviewed literature as the quotient of formation surface/resorption surface and is significantly lower in hip fracture. It is necessary to identify the molecular drivers of these changes in bone turnover. Factors that have been strongly implicated in bone metabolism are therefore divided into three categories, "Vascular", "Anabolic" and "Catabolic". Further data is required from the bone tissue-level microenvironment, of fragility fracture patients, on the variation in molecular signals, and the associated changes in bone structure and remodeling. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 50 条
  • [21] Both falling and bone fragility should be targeted to prevent hip fracture in older adults
    Sugiyama, T.
    Kim, Y. T.
    Oda, H.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (03) : 1277 - 1278
  • [22] Bone Remodeling in Mandible of Wistar Rats with Diabetes Mellitus and Osteoporosis
    Hendrijantini, Nike
    Suisan, Yonatan Christian
    Megantara, Rizko Wira Artha
    Tumali, Bambang Agustono Satmoko
    Kuntjoro, Mefina
    Ari, Muhammad Dimas Aditya
    Sitalaksmi, Ratri Maya
    Hong, Guang
    EUROPEAN JOURNAL OF DENTISTRY, 2023, 17 (02) : 319 - 329
  • [23] Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology
    Li, Siying
    Liu, Gang
    Hu, Siwang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
    Langdahl, Bente
    Ferrari, Serge
    Dempster, David W.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2016, 8 (06) : 225 - 235
  • [25] Genetics of osteoporosis: searching for candidate genes for bone fragility
    Rocha-Braz, Manuela G. M.
    Ferraz-de-Souza, Bruno
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (04): : 391 - 401
  • [26] Osteoporosis-Bone Remodeling and Animal Models
    Bonucci, Ermanno
    Ballanti, Paola
    TOXICOLOGIC PATHOLOGY, 2014, 42 (06) : 957 - 969
  • [27] Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures
    Wu, Yen-Zung
    Huang, Hsuan-Ti
    Cheng, Tsung-Lin
    Lu, Yen-Mou
    Lin, Sung-Yen
    Ho, Cheng-Jung
    Lee, Tien-Ching
    Hsu, Chia-Hao
    Huang, Peng-Ju
    Huang, Han Hsiang
    Li, Jhong-You
    Su, Yu-De
    Chen, Shih-Chieh
    Kang, Lin
    Chen, Chung-Hwan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [28] Bone remodeling in post-menopausal osteoporosis
    Lerner, U. H.
    JOURNAL OF DENTAL RESEARCH, 2006, 85 (07) : 584 - 595
  • [29] Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density
    Hayashi, K.
    Yamamoto, M.
    Murakawa, Y.
    Yamauchi, M.
    Kaji, H.
    Yamaguchi, T.
    Sugimoto, T.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (11) : 1889 - 1894
  • [30] Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density
    K. Hayashi
    M. Yamamoto
    Y. Murakawa
    M. Yamauchi
    H. Kaji
    T. Yamaguchi
    T. Sugimoto
    Osteoporosis International, 2009, 20 : 1889 - 1894